Translationally Controlled Tumor Protein in Prostatic Adenocarcinoma: Correlation with Tumor Grading and Treatment-Related Changes
Prostate cancer is the second leading cause of cancer-related death. The androgen deprivation therapy is the standard treatment for advanced stages. Unfortunately, virtually all tumors become resistant to androgen withdrawal. The progression to castration-resistance is not fully understood, although...
Main Authors: | Bruno Jim Rocca, Alessandro Ginori, Aurora Barone, Calogera Calandra, Filippo Crivelli, Giulia De Falco, Sara Gazaneo, Sergio Tripodi, Gabriele Cevenini, Maria Teresa del Vecchio, Maria Raffaella Ambrosio, Piero Tosi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2015/985950 |
Similar Items
-
Expression of Translationally Controlled Tumor Protein in Human Kidney and in Renal Cell Carcinoma
by: Maria R. Ambrosio, et al.
Published: (2015-01-01) -
Circulating Tumor Cells in the Adenocarcinoma of the Esophagus
by: Giulia Gallerani, et al.
Published: (2016-08-01) -
Tumor to tumor metastasis: Adenocarcinoma of lung metastatic to meningioma
by: A Talukdar, et al.
Published: (2014-01-01) -
Collision Tumor of Adenocarcinoma and Gastrointestinal Stromal Tumor in the Small Bowel
by: Hitoshi Saito, et al.
Published: (2018-11-01) -
Renal infarction due to polyarteritis nodosa in a patient with angioimmunoblastic T-cell lymphoma: a case report and a brief review of the literature
by: Ambrosio Maria, et al.
Published: (2012-05-01)